z-logo
Premium
Superparamagnetic iron oxide particles: contrast media for magnetic resonance imaging
Author(s) -
Lawaczeck Rüdiger,
Menzel Michael,
Pietsch Hubertus
Publication year - 2004
Publication title -
applied organometallic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.53
H-Index - 71
eISSN - 1099-0739
pISSN - 0268-2605
DOI - 10.1002/aoc.753
Subject(s) - iron oxide , chemistry , magnetic resonance imaging , nuclear magnetic resonance , particle size , superparamagnetism , magnetic nanoparticles , nanotechnology , nanoparticle , materials science , magnetic field , magnetization , radiology , physics , medicine , organic chemistry , quantum mechanics
The mainstream magnetic iron oxide particles used as contrast media for magnetic resonance (MR) imaging are composed of a magnetic iron oxide core surrounded by a dextran or carboxydextran coat. The core size ranges from 2 nm to less than 10 nm, and the hydrodynamic diameter ranges from 20 nm to about 120 nm. The coat prevents aggregation and sedimentation of the particles in aqueous solutions, achieves high biological tolerance, and prevents toxic side effects. Two kinds of particles are considered: (i) large particles (>30 nm), called superparamagnetic iron oxide particles (SPIOs) for liver imaging; (ii) smaller particles (<30 nm hydrodynamic diameter), called ultrasmall SPIOs (USPIOs), e.g. for MR angiography. To characterize the particles, Mössbauer spectra are presented for the two particle ensembles. These spectra allow insight into the magnetic coupling, the valency of the iron ions and a rough estimate of the core size to be deduced. On the basis of the concentration dependence of the MR signal intensities, two applications are discussed together with two representative clinical examples. Future indications for MR diagnostics, e.g. the labeling and tracking of stem cells during stem‐cell therapy control, are outlined. Copyright © 2004 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here